{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:41:58Z","timestamp":1778157718737,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.prro.2022.01.014","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T05:53:14Z","timestamp":1646373194000},"page":"348-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Indications for Adjuvant Radiation Therapy in Patients With pN0(i +) Adenocarcinoma of the Endometrium"],"prefix":"10.1016","volume":"12","author":[{"given":"Hima Bindu","family":"Musunuru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Olawaiye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paniti","family":"Sukumvanich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4920-4595","authenticated-orcid":false,"given":"Sushil","family":"Beriwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2022.01.014_bib0001","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: Randomized clinical trial","volume":"100","author":"Benedetti Panici","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.prro.2022.01.014_bib0002","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomised study","volume":"373","author":"group","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.prro.2022.01.014_bib0003","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1470-2045(17)30068-2","article-title":"A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): A multicentre, prospective, cohort study","volume":"18","author":"Rossi","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2022.01.014_bib0004","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/jso.26310","article-title":"Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004)","volume":"123","author":"Altin","year":"2021","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.prro.2022.01.014_bib0005","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1245\/s10434-019-08045-9","article-title":"Size of sentinel node metastasis predicts non-sentinel node involvement in endometrial cancer","volume":"27","author":"Baiocchi","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.prro.2022.01.014_bib0006","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ygyno.2019.04.654","article-title":"Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis","volume":"154","author":"Kennard","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.01.014_bib0007","first-page":"146","article-title":"Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?","author":"Plante","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.01.014_bib0008","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ygyno.2021.02.017","article-title":"Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I\/II endometrioid endometrial cancer: To treat or not to treat?","volume":"161","author":"Backes","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.01.014_bib0009","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2022.01.014_bib0010","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer\u2014A pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2022.01.014_bib0011","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2020.07.024","article-title":"Is the risk of substantial LVSI in stage I endometrial cancer similar to PORTEC in the North American population? A single-institution study","volume":"159","author":"Pifer","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.01.014_bib0012","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"issue":"8 Suppl","key":"10.1016\/j.prro.2022.01.014_bib0013","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2022.01.014_bib0014","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.2004.08.159","article-title":"Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: The Postoperative Radiation Therapy in Endometrial Carcinoma Trial","volume":"22","author":"Creutzberg","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2022.01.014_bib0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/ijgc-2019-000675","article-title":"Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy","volume":"30","author":"Hochreiter","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2022.01.014_bib0016","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/annonc\/mdx753","article-title":"Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer","volume":"29","author":"de Boer","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.prro.2022.01.014_bib0017","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.prro.2022.01.014_bib0018","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: Impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Leon-Castillo","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2022.01.014_bib0019","first-page":"146","article-title":"Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: does adjuvant treatment matter?","author":"Plante","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.01.014_bib0020","first-page":"23","article-title":"Low-volume lymph node metastasis discovered during sentinel lymph node mapping for endometrial carcinoma","author":"St Clair","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.prro.2022.01.014_bib0021","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ygyno.2015.12.028","article-title":"Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion","volume":"140","author":"Zahl Eriksson","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2022.01.014_bib0022","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/jso.25259","article-title":"Clinical significance of isolated tumor cells and micrometastasis in low-grade, stage I endometrial cancer","volume":"118","author":"Piedimonte","year":"2018","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.prro.2022.01.014_bib0023","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/ijgc-2019-000934","article-title":"Retrospective detection of isolated tumor cells by immunohistochemistry in sentinel lymph node biopsy performed for endometrial carcinoma: is there clinical significance?","volume":"30","author":"Goebel","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2022.01.014_bib0024","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ygyno.2021.02.017","article-title":"Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I\/II endometrioid endometrial cancer: To treat or not to treat?","volume":"161","author":"Backes","year":"2021","journal-title":"Gynecol Oncol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850022000650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850022000650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:25:15Z","timestamp":1761819915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850022000650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1879850022000650"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2022.01.014","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indications for Adjuvant Radiation Therapy in Patients With pN0(i +) Adenocarcinoma of the Endometrium","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2022.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}